Highly selective hydrolysis of kinins by recombinant prolylcarboxypeptidase

Biochemical and Biophysical Research Communications

Volumn 405, Issue 3, 2011, Pages 338-343

  Chajkowski, S M ^a   Mallela, J ^b   Watson, D E ^a   Wang, J ^b   McCurdy, C R ^a,b   Rimoldi, J M ^a   Shariat Madar, Z ^b  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Bradykinin 1 8; Dipeptidyl peptidase 7; High molecular weight kininogen; Prekallikrein; Prolylcarboxypeptidase

Indexed keywords

BRADYKININ[1-8]; DIPEPTIDYL PEPTIDASE; KININ; OLIGOPEPTIDE; PROLINE CARBOXYPEPTIDASE;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DOSE RESPONSE; ENZYME METABOLISM; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLITE; MOLECULAR DOCKING; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN HYDROLYSIS; PROTEIN STRUCTURE; SEQUENCE HOMOLOGY;

ANIMALS; BRADYKININ; CARBOXYPEPTIDASES; CATALYTIC DOMAIN; CHROMATOGRAPHY, LIQUID; DNA, COMPLEMENTARY; DROSOPHILA; HUMANS; HYDROGEN BONDING; HYDROLYSIS; KININS; MASS SPECTROMETRY; RECOMBINANT PROTEINS; SUBSTRATE SPECIFICITY;

EID: 79951559173     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.12.036     Document Type: Article

References (39)

1. Wilkinson-Berka J.L., Fletcher E.L. Angiotensin and bradykinin: targets for the treatment of vascular and neuro-glial pathology in diabetic retinopathy. Curr. Pharm. Des. 2004, 10:3313-3330.
2. Campbell D.J. The renin-angiotensin and the kallikrein-kinin systems. Int. J. Biochem. Cell Biol. 2003, 35:784-791.
3. Fabiani M.E., Dinh D.T., Story D.F. Interaction of the renin-angiotensin system, bradykinin and sympathetic nerves with cholinergic transmission in the rat isolated trachea. Br. J. Pharmacol. 1997, 122:1089-1098.
4. Campbell D.J. The kallikrein-kinin system in humans. Clin. Exp. Pharmacol. Physiol. 2001, 28:1060-1065.
5. Allikmets K., Parik T., Viigimaa M. The renin-angiotensin system in essential hypertension: associations with cardiovascular risk. Blood Press. 1999, 8:70-78.
6. Castro-Chaves P., Pintalhao M., Fontes-Carvalho R., Cerqueira R., Leite-Moreira A.F. Acute modulation of myocardial function by angiotensin 1-7. Peptides 2009, 30:1714-1719.
7. Hisada Y., Sugaya T., Yamanouchi M., Uchida H., Fujimura H., Sakurai H., Fukamizu A., Murakami K. Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice. J. Clin. Invest. 1999, 103:627-635.
8. Geara A.S., Azzi J., Jurewicz M., Abdi R. The renin-angiotensin system: an old, newly discovered player in immunoregulation. Transplant. Rev. (Orlando.) 2009, 23:151-158.
9. Ager E.I., Neo J., Christophi C. The renin-angiotensin system and malignancy. Carcinogenesis 2008, 29:1675-1684.
10. Daniels M.D., Hyland K.V., Engman D.M. Treatment of experimental myocarditis via modulation of the renin-angiotensin system. Curr. Pharm. Des. 2007, 13:1299-1305.
11. Duke L.M., Eppel G.A., Widdop R.E., Evans R.G. Disparate roles of AT2 receptors in the renal cortical and medullary circulations of anesthetized rabbits. Hypertension 2003, 42:200-205.
12. Sleat D.E., Wang Y., Sohar I., Lackland H., Li Y., Li H., Zheng H., Lobel P. Identification and validation of mannose 6-phosphate glycoproteins in human plasma reveal a wide range of lysosomal and non-lysosomal proteins. Mol. Cell Proteomics 2006, 5:1942-1956.
13. Skidgel R.A., Erdos E.G. Cellular carboxypeptidases. Immunol. Rev. 1998, 161:129-141.
14. Mallela J., Perkins R., Yang J., Pedigo S., Rimoldi J.M., Shariat-Madar Z. The functional importance of the N-terminal region of human prolylcarboxypeptidase. Biochem. Biophys. Res. Commun. 2008, 374:635-640.
15. Hooley E., McEwan P.A., Emsley J. Molecular modeling of the prekallikrein structure provides insights into high-molecular-weight kininogen binding and zymogen activation. J. Thromb. Haemost. 2007, 5:2461-2466.
16. Shariat-Madar Z., Mahdi F., Schmaier A.H. Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator. J. Biol. Chem. 2002, 277:17962-17969.
17. Wu Y., Dai J., Schmuckler N.G., Bakdash N., Yoder M.C., Overall C.M., Colman R.W. Cleaved high molecular weight kininogen inhibits tube formation of endothelial progenitor cells via suppression of matrix metalloproteinase 2. J. Thromb. Haemost. 2009, 8:185-193.
18. Iwaki T., Castellino F.J. Plasma levels of bradykinin are suppressed in factor XII-deficient mice. Thromb. Haemost. 2006, 95:1003-1010.
19. Zhu L., Carretero O.A., Liao T.D., Harding P., Li H., Sumners C., Yang X.P. Role of prolylcarboxypeptidase in angiotensin II type 2 receptor-mediated bradykinin release in mouse coronary artery endothelial cells. Hypertension 2010, 56:384-390.
20. Isordia-Salas I., Sainz I.M., Pixley R.A., Martinez-Murillo C., Colman R.W. High molecular weight kininogen in inflammation and angiogenesis: a review of its properties and therapeutic applications. Rev. Invest. Clin. 2005, 57:802-813.
21. Sharma J.N., Al-Sherif G.J. Pharmacologic targets and prototype therapeutics in the kallikrein-kinin system: bradykinin receptor agonists or antagonists. Sci. World J. 2006, 6:1247-1261.
22. Feterik K., Smith L., Katusic Z.S. Angiotensin-(1-7) causes endothelium-dependent relaxation in canine middle cerebral artery. Brain Res. 2000, 873:75-82.
23. Sharma J.N. Hypertension and the bradykinin system. Curr. Hypertens. Rep. 2009, 11:178-181.
24. Dharmani M., Mustafa M.R., Achike F.I., Sim M.K. Effects of angiotensin 1-7 on the actions of angiotensin II in the renal and mesenteric vasculature of hypertensive and streptozotocin-induced diabetic rats. Eur. J. Pharmacol. 2007, 561:144-150.
25. Hoffmann G., Dusing R. ACE-inhibition, kinins, and vascular PGI2 synthesis. Eicosanoids 1992, 5(Suppl.):S60-S62.
26. Mallela J., Yang J., Shariat-Madar Z. Prolylcarboxypeptidase: a cardioprotective enzyme. Int. J. Biochem. Cell Biol. 2009, 41:477-481.
27. Schmaier A.H. The plasma kallikrein-kinin system counterbalances the renin-angiotensin system. J. Clin. Invest. 2002, 109:1007-1009.
28. Deddish P.A., Skidgel R.A., Kriho V.B., Li X.Y., Becker R.P., Erdos E.G. Carboxypeptidase M in Madin-Darby canine kidney cells. Evidence that carboxypeptidase M has a phosphatidylinositol glycan anchor. J. Biol. Chem. 1990, 265:15083-15089.
29. Shariat-Madar Z., Mahdi F., Schmaier A.H. Recombinant prolylcarboxypeptidase activates plasma prekallikrein. Blood 2004, 103:4554-4561.
30. Ngo M.L., Mahdi F., Kolte D., Shariat-Madar Z. Upregulation of prolylcarboxypeptidase (PRCP) in lipopolysaccharide (LPS) treated endothelium promotes inflammation. J. Inflamm. (Lond). 2009, (6):3.
31. Cui L., Nithipatikom K., Campbell W.B. Simultaneous analysis of angiotensin peptides by LC-MS and LC-MS/MS: metabolism by bovine adrenal endothelial cells. Anal. Biochem. 2007, 369:27-33.
32. Zhao Y., Qiu Q., Mahdi F., Shariat-Madar Z., Rojkjaer R., Schmaier A.H. Assembly and activation of HK-PK complex on endothelial cells results in bradykinin liberation and NO formation. Am. J. Physiol. Heart Circ. Physiol. 2001, 280:H1821-H1829.
33. Soisson S.M., Patel S.B., Abeywickrema P.D., Byrne N.J., Diehl R.E., Hall D.L., Ford R.E., Reid J.C., Rickert K.W., Shipman J.M., Sharma S., Lumb K.J. Structural definition and substrate specificity of the S28 protease family: the crystal structure of human prolylcarboxypeptidase. BMC. Struct. Biol. 2010, 10:16.
34. Zhao X., Southwick K., Cardasis H.L., Du Y., Lassman M.E., Xie D., El-Sherbeini M., Geissler W.M., Pryor K.D., Verras A., Garcia-Calvo M., Shen D.M., Yates N.A., Pinto S., Hendrickon R.C. Peptidomic profiling of human cerebrospinal fluid identifies YPRPIHPA as a novel substrate for prolylcarboxypeptidase. Proteomics. 2010, 10:2882-2886.
35. Moreira C.R., Schmaier A.H., Mahdi F., da M.G., Nader H.B., Shariat-Madar Z. Identification of prolylcarboxypeptidase as the cell matrix-associated prekallikrein activator. FEBS Lett. 2002, 523:167-170.
36. Burley S.K. An overview of structural genomics. Nat. Struct. Biol. 2000, 7(Suppl.):932-934.
37. Ginalski K., Grishin N.V., Godzik A., Rychlewski L. Practical lessons from protein structure prediction. Nucleic Acids Res. 2005, 33:1874-1891.
38. Liu M., Bayjanov J.R., Renckens B., Nauta A., Siezen R.J. The proteolytic system of lactic acid bacteria revisited: a genomic comparison. BMC. Genomics 2010, 11:36.
39. Fulop V., Bocskei Z., Polgar L. Prolyl oligopeptidase: an unusual beta-propeller domain regulates proteolysis. Cell 1998, 94:161-170.